Short answer: It can, and it is one of the more common side effects. In the WHI trial, 9.3% of women on estrogen plus progestin who had no breast tenderness at the start developed it, compared with 2.4% on placebo. In the HERS trial, breast symptoms were reported by 40% of women on hormones in year 1 and 13% by year 4. Labels list breast pain among the common reactions.
| Source | Hormone group | Comparison |
|---|---|---|
| Premarin label, year 1 of a 2-year trial (women 40 to 65) | 11% on 0.625 mg, 12% on 0.45 mg, 7% on 0.3 mg | 8% on placebo |
| WHI estrogen + progestin, new tenderness at year 1 (Barnabei 2005) | 9.3% | 2.4% on placebo |
| HERS, estrogen + progestin (Barnabei 2002) | 40% in year 1, 13% by year 4 | Placebo reported less |
The WHI trial gave 16,608 women aged 50 to 79 with a uterus Premarin 0.625 mg plus medroxyprogesterone 2.5 mg or placebo; its 9.3% figure counts only women who had no breast tenderness when they started. The Premarin numbers come from the label's treatment-related reactions table, where the two higher doses had more breast pain than the lowest dose and placebo. The Premarin label lists breast pain among its most common adverse reactions and says women should be told about common reactions such as breast pain and tenderness.
The HERS trial gave 2,763 older women with heart disease and a uterus Premarin 0.625 mg plus medroxyprogesterone 2.5 mg or placebo. Breast symptoms in the hormone group fell from 40% at 1 year to 13% by the 4th year. These women averaged 67 years old and 18 years past menopause, so the pattern may differ in younger women starting therapy. The same women on hormones reported fewer hot flashes, less vaginal dryness and less trouble sleeping than on placebo.
The Premarin label also lists breast tenderness among the effects of taking too much estrogen. If tenderness does not ease, the dose and product are for the prescriber to review.
Tenderness on both sides that comes with starting or raising a dose is the pattern the trials describe. The Estring patient leaflet lists new breast lumps among the warning signs to call a provider about right away, and advises a breast exam and a mammogram every year unless the provider says otherwise. See hormone therapy and mammograms for how hormones can change mammogram density.
Because breast tenderness often changes over the first months, a simple log shows the trend better than memory. Dose Track can record a symptom note with each dose, so the prescriber can see whether tenderness is fading, steady, or tied to a dose change.
Read more on Dose Track: Premarin side effects · Estradiol tablet side effects · Menopause · Women's Health Initiative